Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

Update Il y a 4 ans
Reference: NCT00775255

  • | Country :
  • India
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the single-dose oral bioavailability of clarithromycin 250-mg/5 mL powder for oral suspension of Ranbaxy Laboratories with that of Abbott Laboratories (Biaxin®) following administration of a 250 mg/5 mL dose in healthy, adult, human, male subjects under fasting conditions.


Inclusion criteria

  • Healthy

Links